Europe OKs first one-dose drug to protect babies against RSV- it’s from AstraZeneca

Sharing is Caring!

‘The European Commission has authorized the world’s first one-dose drug against a respiratory virus that sickens millions of babies and children globally every year.
In a statement Friday, drugmakers Sanofi and AstraZeneca said the European Commission had given the green light to nirsevimab, a laboratory-developed antibody designed to protect infants during their first exposure to RSV, or respiratory syncytial virus, a highly contagious common infection that infects nearly all babies by age 2.’

See also  THIS WOULD BE HUGE: A possible vaccine against the bacteria that cause UTIs.

See also  New Zealand accepts house price falls and recession to protect the Kiwi Dollar

Views: 69

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.